The Trump administration’s third budget has proposed broad cuts to federal R&D spending.
A budget proposal for the 2020 fiscal year, which begins on 1 October 2019, was announced by the White House on 11 March. Reactions and the fates of previous proposals suggest it is likely to be substantially altered by Congress.
The proposal includes $33.5 billion for the National Institutes of Health—$4.5bn less than in 2019—with $1.3bn ring-fenced for opioid and pain research. Illinois Democratic senator Dick Durbin called the cut an “outrage”.